GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA1A, ADRB1, AKR1B1, APEX1, APP, AR, AURKB, AXL, CA12, CA2, CA7, CACNA1C, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, EGFR, F3, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HSD17B1, HSD17B2, HSD17B3, HTR1A, HTR2A, HTR2B, HTR7, KDR, MAOA, MET, MIF, POLA1, POLB, SLC1A1, SRC, TNKS, TNKS2, XDH |
13.8179 |
[BP] GO:0007187 |
None
|
ADORA1, ADRA1A, ADRB1, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR5A, HTR6, HTR7 |
13.6047 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA1A, ADRB1, CHRM2, CNR1, DRD1, DRD2, DRD3, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR5A, HTR7 |
12.1527 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, ADRA1A, APP, CA2, CA7, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR2A |
11.696 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, ADRA1A, APP, CA2, CA7, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR2A |
11.696 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA1A, ADRB1, AKR1B1, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, GRM1, HTR2A, HTR2B, HTR6, KDR, MAP2K1, MAP3K7, MET, MIF, MMP9, RELA, SRC, TNKS, TNKS2, XDH |
11.2567 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA1A, ADRB1, AKR1B1, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, GRM1, HTR2A, HTR2B, HTR6, KDR, MAP2K1, MAP3K7, MET, MIF, MMP9, RELA, SRC, TNKS, TNKS2, XDH |
11.2398 |
[BP] GO:0007193 |
None
|
ADORA1, CHRM2, DRD2, DRD3, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR5A, HTR7 |
10.3932 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AR, AXL, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, FABP3, GRIK5, GRM5, HSD17B2, HTR5A, IGF1R, MMP2, MMP9, POLB, PTGES, RELA, SRC, TYR |
10.1405 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, CNR1, DRD1, DRD2, EGFR, GRM1, GRM3, GRM5, GRM8, HTR2A |
10.0432 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA1A, ADRB1, AKR1B1, APP, AR, AURKB, AXL, CA2, CA7, CACNA1C, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP9, RELA, SRC, TNKS, TNKS2, XDH |
9.90308 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA1A, ADRB1, AKR1B1, APP, AR, AURKB, AXL, CA2, CA7, CACNA1C, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP9, RELA, SRC, TNKS, TNKS2, XDH |
9.76744 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA1A, ADRB1, AKR1B1, APP, AR, AXL, CYP1B1, DRD2, EGFR, ERBB2, F3, FLT3, GRM1, HTR2A, HTR2B, HTR6, KDR, MAP2K1, MAP3K7, MET, MIF, RELA, SRC, XDH |
9.51221 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA1A, ADRB1, AKR1B1, APP, AR, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, GRM1, HTR2A, HTR2B, HTR6, KDR, MAP2K1, MAP3K7, MET, MIF, MMP9, RELA, SRC, TNKS, TNKS2, XDH |
9.30423 |
[BP] GO:0010033 |
response to organic substance
|
ADRA1A, AKR1B1, APEX1, APP, AR, AXL, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD17B2, HTR5A, IGF1R, KDR, MMP2, POLB, PTGES, RELA, SRC, TYR |
9.25341 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD2, EGFR, ERBB2, FABP3, FABP4, FUT7, HSD17B1, HSD17B2, HSD17B3, MET, MIF, PTGES, TBXAS1 |
9.2492 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA1A, ADRB1, AKR1B1, APP, AR, AXL, CA1, CA2, CACNA1C, CHRM2, CNR1, CNR2, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP2, MMP9, PIM1, POLB, PTGES, RELA, SIGMAR1, SRC, TNKS, TNKS2 |
8.95515 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA1A, ADRB1, AKR1B1, APEX1, APP, AXL, CA12, CA2, CA7, CACNA1C, CNR1, DRD1, DRD2, DRD3, EGFR, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HTR2A, HTR2B, MET, POLA1, POLB, SRC |
8.89049 |
[BP] GO:0042221 |
response to chemical
|
ADRA1A, AKR1B1, APEX1, APP, AR, AXL, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD17B2, HTR2A, HTR2B, HTR5A, IGF1R, KDR, MMP2, MMP9, POLB, PTGES, RELA, SRC, TYR |
8.79516 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, MIF, PTGES, TBXAS1 |
8.07901 |
[BP] GO:0007215 |
None
|
APP, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
8.05891 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, CACNA1C, CNR1, DRD1, DRD2, DRD3, EGFR, HTR2A, HTR2B, KDR, MIF, SRC, TNKS, TNKS2 |
7.94963 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, AKR1B1, APP, AR, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ERBB2, F3, FABP3, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MIF, MMP2, MMP9, PIM1, PTGES, RELA, SRC, XDH |
7.88097 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, MIF, PTGES, TBXAS1 |
7.85566 |
[BP] GO:0014070 |
response to organic cyclic compound
|
APEX1, APP, AR, CA2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, FLT3, HTR5A, PTGES, RELA, SRC, TYR |
7.79524 |
[BP] GO:0042493 |
response to drug
|
ADRA1A, AKR1B1, APEX1, AXL, CA9, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, FABP3, HTR2A, HTR2B, KDR, POLB, RELA, SRC |
7.70984 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA1A, ADRB1, AKR1B1, APP, AR, AXL, CNR1, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ERBB2, F3, FABP4, FLT3, GRM1, HTR2A, HTR2B, HTR6, KDR, MAP2K1, MAP3K7, MET, MIF, MMP2, MMP9, RELA, SRC, TNKS, TNKS2, XDH |
7.70984 |
[BP] GO:0099536 |
None
|
CHRM2, CNR1, DRD1, DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR6, HTR7, SLC1A1 |
7.70984 |
[BP] GO:0099537 |
None
|
CHRM2, CNR1, DRD1, DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR6, HTR7, SLC1A1 |
7.70984 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TYR |
7.6556 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA1A, ADRB1, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, GRM1, HTR2A, HTR2B, HTR6, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP9, RELA, SRC, XDH |
7.58194 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA1A, APP, AR, DRD2, EGFR, ERBB2, FLT3, GRM1, HTR2A, HTR2B, KDR, MAP2K1, MAP3K7, MIF, SRC, XDH |
7.5591 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, ADRA1A, CA2, CA7, CNR1, CNR2, DRD2 |
7.53442 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, ALDH2, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, FABP3, FUT7, GLO1, HSD17B3, HTR2B, MIF, PIM1, PTGES, TBXAS1, TYR, XDH |
7.48543 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGES, TBXAS1 |
7.48543 |
[BP] GO:0023052 |
None
|
ADORA1, ADRA1A, ADRB1, AR, CACNA1C, CHRM2, CNR1, DRD1, DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR6, HTR7, SLC1A1 |
7.29088 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP4, KDR, MMP9, PTGES, RELA, SRC |
7.2755 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, APEX1, AR, AURKB, AXL, CNR1, CSNK2A1, CYP1B1, EGFR, F3, FLT3, GLO1, GRIK5, HTR2B, IGF1R, KDR, MAP2K1, MET, MIF, MMP9, PIM1, RELA, SIGMAR1, SRC, TOP2A, XDH |
7.25403 |
[BP] GO:0007267 |
None
|
ADORA1, ADRA1A, ADRB1, AR, CHRM2, CNR1, DRD1, DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR6, HTR7, SLC1A1 |
7.17461 |
[BP] GO:0007268 |
None
|
CHRM2, DRD1, DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR6, HTR7, SLC1A1 |
6.84981 |
[BP] GO:0098916 |
None
|
CHRM2, DRD1, DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR6, HTR7, SLC1A1 |
6.84981 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRB1, AKR1B1, APEX1, APP, AR, AURKB, AXL, CA2, CA9, CHRM2, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, IGF1R, KDR, MAP2K1, MAP3K7, MIF, MMP2, MMP9, POLA1, POLB, PTGES, RELA, SRC, TOP2A, TYR |
6.84745 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CACNA1C, CNR1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, EGFR, HSD17B1, HSD17B2, HSD17B3, HTR1A, HTR2A |
6.73151 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, APEX1, AR, AURKB, AXL, CNR1, CSNK2A1, CYP1B1, EGFR, F3, FLT3, GLO1, GRIK5, HTR2B, IGF1R, KDR, MAP2K1, MIF, MMP9, PIM1, RELA, SIGMAR1, SRC, TOP2A, XDH |
6.69316 |
[BP] GO:0007210 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.69128 |
[BP] GO:0098664 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.69128 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.66224 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, HSD17B1, HSD17B2, HSD17B3 |
6.66224 |
[BP] GO:0007154 |
None
|
ADORA1, ADRA1A, ADRB1, AR, AXL, CACNA1C, CHRM2, CNR1, DRD1, DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR6, HTR7, SLC1A1 |
6.66224 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, APEX1, AR, AURKB, AXL, CNR1, CSNK2A1, CYP1B1, EGFR, F3, FLT3, GLO1, GRIK5, HTR2B, IGF1R, KDR, MAP2K1, MET, MIF, MMP9, PIM1, RELA, SIGMAR1, SRC, TOP2A, XDH |
6.65486 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, ADRA1A, ADRB1, APP, CA2, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1, SRC |
6.65171 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, ADRB1, APP, AR, DRD1, DRD2, EGFR, ERBB2, FABP3, FLT3, GRM1, GRM5, HTR2A, HTR2B, KDR, MAP2K1, MAP3K7, MIF, MMP9, SRC, XDH |
6.44829 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA1A, ADRB1, APP, AR, DRD1, DRD2, EGFR, ERBB2, FABP3, FLT3, GRM1, GRM5, HTR2A, HTR2B, KDR, MAP2K1, MAP3K7, MIF, MMP9, SRC, XDH |
6.44829 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, MIF, PTGES, TBXAS1 |
6.44639 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA1A, ADRB1, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7, SRC |
6.44639 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA1A, APP, AR, DRD2, EGFR, ERBB2, FLT3, GRM1, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MIF, SRC, XDH |
6.39038 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, HTR2A, HTR2B, KDR, SRC |
6.379 |
[BP] GO:0033993 |
response to lipid
|
AR, AXL, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, EGFR, FABP3, FLT3, HSD17B2, HTR5A, PTGES, RELA, SRC, TYR |
6.3709 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, APEX1, AXL, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, KDR, POLB, RELA, SRC |
6.29774 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA1A, ADRB1, AKR1B1, APEX1, APP, AR, AURKB, AXL, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FABP3, FLT3, GRIK5, GRM1, GRM5, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP2, MMP9, PIM1, RELA, SRC, TNKS, TNKS2, TOP2A, XDH |
6.2942 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRA1A, ADRB1, AKR1B1, APEX1, APP, AR, AURKB, AXL, CA2, CA9, CACNA1C, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ERBB2, FABP4, FLT3, FUT7, GLO1, HSD17B2, HSD17B3, HTR2A, HTR2B, HTR5A, KDR, MAP2K1, MET, MIF, MMP2, MMP9, PIM1, POLB, RELA, SIGMAR1, SRC, TNKS2, TOP2A, TYR |
6.24584 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA1A, ADRB1, APP, AR, DRD1, DRD2, DRD3, EGFR, ERBB2, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MIF, MMP9, SRC, XDH |
6.17799 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, ALDH2, APP, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, HSD17B3, HTR1A, MAOA, TYR |
6.15575 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA1A, AKR1B1, APP, CA12, CA2, CA7, CACNA1C, CNR1, DRD1, DRD2, DRD3, EGFR, FABP3, FABP4, GRIK5, GRM1, GRM5, HTR2A, HTR2B, MET |
6.12556 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, ADRB1, APP, AR, DRD1, DRD2, DRD3, EGFR, ERBB2, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MIF, MMP9, SRC, XDH |
6.1151 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA1A, ADRB1, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7 |
6.11489 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA1A, ADRB1, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7 |
6.11489 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA1A, ADRB1, APP, AR, AURKB, CNR1, CNR2, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FABP4, FLT3, GRM1, GRM3, GRM5, HTR2A, HTR2B, IGF1R, MAP2K1, MAP3K7, MIF, MMP9, SRC, TNKS, XDH |
6.07293 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD2, EGFR, ERBB2, FABP3, FABP4, FUT7, MET, MIF, PTGES, TBXAS1 |
5.99558 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA1A, ADRB1, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7 |
5.8908 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
ADRA1A, ADRB1, CACNA1C, DRD1, DRD2, DRD3, EGFR, GRM5, HTR2B, HTR5A, KDR |
5.89073 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA1A, ADRB1, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7 |
5.86967 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA1A, AKR1B1, APEX1, APP, AR, CA2, CA9, CSNK2A1, CYP1A2, DRD1, EGFR, ERBB2, FABP3, FLT3, GRM5, HTR5A, IGF1R, MMP2, RELA, SRC |
5.868 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AR, CSNK2A1, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MIF, MMP2, MMP9, PIM1, RELA |
5.84875 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, ALDH2, ALOX5, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, HSD17B1, HSD17B2, HSD17B3, MAOA, TBXAS1, TYR, XDH |
5.76954 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA1A, ADRB1, AKR1B1, ALOX5, APP, AR, AXL, CACNA1C, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, F3, FABP4, GRM1, GRM5, GRM8, HSD17B2, HTR1A, HTR2A, HTR2B, HTR7, IGF1R, MET, MMP1, MMP2, MMP9, PIM1, RELA, SRC, TNKS2, TYR |
5.73692 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.71803 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.6692 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.6692 |
[BP] GO:0050795 |
None
|
ADORA1, CNR1, DRD2, DRD3, HTR1A, HTR2A, HTR2B |
5.655 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA1A, ADRB1, AKR1B1, APEX1, APP, AR, AURKB, AXL, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP2, MMP9, PIM1, RELA, SLC1A1, SRC, TNKS, TNKS2, TOP2A, XDH |
5.64703 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGES, TBXAS1 |
5.63341 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ADRA1A, APP, DRD2, EGFR, HTR2A, HTR2B, KDR, MAP2K1, MIF, SRC |
5.57253 |
[BP] GO:0097756 |
None
|
ADORA1, ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
5.52301 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, CA1, CSNK2A1, DRD2, EGFR, ERBB2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MAP3K7, MET, MIF, MMP2, MMP9, RELA, SRC, TNKS, TNKS2 |
5.49823 |
[BP] GO:0042391 |
None
|
ADORA1, ADRA1A, APP, CACNA1C, CNR1, CNR2, DRD1, GRIA2, GRIA4, GRIK5, GRM5, KDR, SRC |
5.46789 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, GRM1, HTR2A, HTR2B, MAP2K1, MAP3K7, MIF, SRC |
5.43596 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA1A, APP, AR, DRD2, EGFR, ERBB2, FLT3, GRM1, GRM5, HTR2A, HTR2B, KDR, MAP2K1, MAP3K7, MIF, MMP9, SRC, XDH |
5.43268 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA1A, ADRB1, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7, SRC |
5.42803 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD17B1, HSD17B2, HSD17B3 |
5.39886 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, MMP9, RELA, SRC |
5.39886 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA1A, ADRB1, AKR1B1, AXL, CACNA1C, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, GRM5, HTR2A, HTR2B, HTR5A, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, POLB, RELA, SRC |
5.39788 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA1A, ADRB1, APP, AR, AXL, CA2, CNR1, CYP1B1, DRD2, DRD3, EGFR, F3, HTR2A, HTR2B, KDR, MAP2K1, MAP3K7, MET, MIF, MMP9, PIM1, RELA, SLC1A1, SRC |
5.36556 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APEX1, APP, AR, AXL, CA2, CA7, CACNA1C, CNR1, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, GRIK5, GRM5, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MET, MIF, MMP9, SRC |
5.36556 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.35482 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, APP, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, FABP3, FLT3, GRM5, IGF1R, MMP2, RELA, SRC, TYR |
5.34013 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, GRM1, HTR2A, HTR2B, IGF1R, MAP2K1, MAP3K7, MIF, SRC |
5.3294 |
[BP] GO:0048513 |
animal organ development
|
ACHE, ADRA1A, AR, AXL, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ERBB2, FLT3, HSD17B2, HSD17B3, KDR, MAP2K1, POLB, RELA, SRC, TYR |
5.31722 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ADRA1A, APP, DRD2, EGFR, ERBB2, HTR2A, HTR2B, KDR, MAP2K1, MIF, SRC |
5.30839 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
5.18427 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA1A, APP, AR, DRD2, EGFR, ERBB2, FLT3, GRM1, GRM5, HTR2A, HTR2B, KDR, MAP2K1, MAP3K7, MIF, MMP9, SRC, XDH |
5.16752 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APEX1, APP, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, IGF1R, KDR, MET, MIF, MMP9, SRC |
5.12174 |
[BP] GO:0018958 |
None
|
AKR1B1, DRD1, DRD2, DRD3, HTR1A, MAOA, TYR |
5.12174 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APEX1, APP, CACNA1C, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, ERBB2, F3, IGF1R, KDR, MET, MIF, MMP9, SRC |
5.10806 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, ADRB1, AKR1B1, APP, AURKB, CA2, CYP1A1, DRD1, DRD2, DRD3, EGFR, GRM1, HTR2A, HTR2B, MMP2, POLB, RELA, SRC, TYR |
5.09188 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, CNR1, DRD1, DRD2, DRD3, EGFR, TNKS, TNKS2 |
5.08857 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, ADRA1A, APP, CA2, CA7, DRD1, DRD2, EGFR |
5.06855 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA1A, ADRB1, APP, AR, AURKB, CNR1, CNR2, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FABP4, FLT3, GRM1, GRM3, GRM5, HTR2A, HTR2B, IGF1R, MAP2K1, MAP3K7, MET, MIF, MMP9, PIM1, RELA, SRC, TNKS, XDH |
5.05734 |
[BP] GO:0006939 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
5.04731 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, ALDH2, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, EGFR, MAOA |
5.01328 |
[BP] GO:0007568 |
aging
|
ADRA1A, APEX1, AURKB, CNR1, CYP1A1, HTR2A, MAP2K1, MIF, POLB, RELA |
5.01328 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, MIF, PTGES, TBXAS1 |
5.01268 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA1A, APP, AR, DRD1, DRD2, EGFR, ERBB2, FABP4, FLT3, GRM1, GRM5, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MIF, MMP9, SRC, XDH |
4.92902 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, APP, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, FABP3, FLT3, GRM5, IGF1R, MMP2, RELA, SRC, TYR |
4.91734 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APEX1, APP, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, ERBB2, F3, IGF1R, KDR, MET, MIF, MMP9, SRC |
4.90492 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, APEX1, APP, AR, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, ERBB2, FABP4, FLT3, GRIK5, GRM1, GRM5, IGF1R, KDR, MAP2K1, MAP3K7, MIF, MMP2, MMP9, POLA1, POLB, RELA, SRC, TOP2A |
4.86352 |
[BP] GO:0007200 |
None
|
ADRA1A, CHRM2, DRD1, DRD2, GRM5, HTR2A, HTR2B |
4.84361 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD17B1, HSD17B2, HSD17B3 |
4.79538 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRB1, AKR1B1, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA7, CA9, CACNA1C, CHRM2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FABP3, FABP4, FLT3, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD17B1, HSD17B2, HSD17B3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, PTGES, RELA, SIGMAR1, SLC1A1, SRC, TNKS, TNKS2, TOP2A, XDH |
4.78126 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
4.78056 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
4.72384 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, CYP1A1, EGFR, ERBB2, FLT3, HTR1A, MAP2K1, MET, MIF, PIM1, POLA1, SRC, TYR |
4.71014 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRB1, AKR1B1, ALDH2, ALOX5, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CACNA1C, CHRM2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FABP3, FABP4, FLT3, FUT7, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD17B1, HSD17B2, HSD17B3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, PTGES, RELA, SIGMAR1, SLC1A1, SRC, TBXAS1, TNKS, TNKS2, TOP2A, TYR, XDH |
4.69574 |
[BP] GO:0042310 |
None
|
ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
4.69574 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, DRD3, EGFR, GRIK5, HTR1A, MAOA, SLC1A1 |
4.65473 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA1A, ADRB1, APP, AR, AXL, CA2, CACNA1C, CHRM2, CNR1, CYP1B1, DRD2, DRD3, EGFR, ERBB2, F3, GRM1, HTR2A, HTR2B, KDR, MAP2K1, MAP3K7, MET, MIF, MMP9, PIM1, RELA, SLC1A1, SRC, TNKS2, XDH |
4.61285 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, EGFR, GLO1, HTR2B, IGF1R, KDR, MET, MIF, MMP9, PIM1, RELA, SRC |
4.60698 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, PIM1, SRC |
4.60698 |
[BP] GO:0050801 |
ion homeostasis
|
ADRA1A, APP, CA12, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, EGFR, FABP3, GRM1, GRM5, HTR2A, HTR2B |
4.60115 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APEX1, APP, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, IGF1R, KDR, MET, MIF, MMP9, SRC |
4.56861 |
[BP] GO:0001659 |
None
|
ADORA1, ADRB1, DRD1, DRD2, HTR2A |
4.5652 |
[BP] GO:0032845 |
None
|
ADORA1, DRD2, HTR2A, HTR2B, MIF, SRC, TNKS, TNKS2 |
4.55764 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, APEX1, APP, AR, AURKB, AXL, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, EGFR, ERBB2, FABP3, FABP4, GLO1, GRM3, GRM8, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MET, MIF, MMP9, PIM1, PTGES, RELA, SRC, TNKS, TNKS2, TOP2A, XDH |
4.52766 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, AURKB, DRD2, EGFR, ERBB2, FLT3, GRM1, GRM5, HTR2A, HTR2B, MAP2K1, MAP3K7, MIF, SRC, TNKS |
4.48791 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD17B1, HSD17B2, HSD17B3 |
4.48791 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, APP, DRD2, EGFR, ERBB2, FABP4, FLT3, GRM1, GRM5, HTR2A, HTR2B, IGF1R, MAP2K1, MAP3K7, MIF, SRC |
4.45591 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA1A, ADRB1, APP, AR, AURKB, DRD2, EGFR, ERBB2, F3, FLT3, GRM1, GRM5, HTR2A, HTR2B, MAP2K1, MAP3K7, MET, MIF, MMP9, RELA, SRC, TNKS, XDH |
4.4552 |
[BP] GO:0007198 |
None
|
HTR1A, HTR5A, HTR7 |
4.42503 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.41418 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, AURKB, DRD2, EGFR, ERBB2, FABP4, FLT3, GRM1, GRM5, HTR2A, HTR2B, IGF1R, MAP2K1, MAP3K7, MIF, SRC, TNKS |
4.39228 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, DRD2, EGFR, ERBB2, FLT3, GRM1, GRM5, HTR2A, HTR2B, MAP2K1, MAP3K7, MIF, SRC |
4.38034 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, CNR2, DRD1, DRD2, HTR2A |
4.38034 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, EGFR, ERBB2, F3, MET, SRC, XDH |
4.37812 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA1A, APP, AR, DRD1, DRD2, EGFR, ERBB2, FABP4, FLT3, GRM1, GRM5, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MIF, MMP9, SRC, XDH |
4.36495 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, GRM1, HTR2A, HTR2B, MAP2K1, MAP3K7, MIF, SRC |
4.36328 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, APP, CA2, CA7, CACNA1C, CNR1, DRD1, DRD2, DRD3, GRM5, HTR1A, HTR2A, MIF, MMP9 |
4.35762 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, EGFR, HTR6 |
4.33295 |
[BP] GO:0003008 |
None
|
ADORA1, ADRA1A, ADRB1, AKR1B1, APP, CNR1, CNR2, CYP1B1, DRD1, DRD2, DRD3, EGFR, GRM1, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR7, SRC, TYR |
4.33295 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRA1A, ADRB1, CACNA1C, CHRM2, DRD2, EGFR, HTR2A, SLC1A1 |
4.27664 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CSNK2A1, DRD1, EGFR, ERBB2, FLT3, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TNKS |
4.21317 |
[BP] GO:0042737 |
drug catabolic process
|
ACHE, ALDH2, CYP1A2, CYP2A6, CYP2D6, CYP3A4, MAOA |
4.13117 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, EGFR, GLO1, HTR2B, IGF1R, KDR, MET, MIF, MMP9, PIM1, RELA, SRC |
4.12185 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, DRD2, EGFR, ERBB2, FLT3, GRM1, GRM5, HTR2A, HTR2B, MAP2K1, MAP3K7, MIF, SRC |
4.10113 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
ADRA1A, APP, CA12, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, EGFR, GRM1, GRM5, HTR2A, HTR2B |
4.10113 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, APP, DRD2, EGFR, ERBB2, FABP4, FLT3, GRM1, GRM5, HTR2A, HTR2B, IGF1R, MAP2K1, MAP3K7, MIF, SRC |
4.08595 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, EGFR, GLO1, HTR2B, IGF1R, KDR, MIF, MMP9, PIM1, RELA, SRC |
4.0478 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, ADRB1, AKR1B1, DRD1, DRD2, HTR2A, MET |
4.04417 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AR, AXL, CYP1B1, DRD1, EGFR, GRIK5, GRM5, IGF1R, MMP2, MMP9, RELA, SRC |
4.02397 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, MMP9, RELA, SRC |
4.00338 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA1A, APP, AR, DRD2, EGFR, ERBB2, FLT3, GRM1, GRM5, HTR2A, HTR2B, KDR, MAP2K1, MAP3K7, MIF, MMP9, SRC, XDH |
4.00075 |
[BP] GO:0051952 |
None
|
ADORA1, CNR1, DRD1, DRD2, DRD3, HTR2A |
3.98498 |
[BP] GO:0009725 |
response to hormone
|
ADRA1A, AKR1B1, APEX1, AR, CA2, CA9, CSNK2A1, CYP1A2, EGFR, FABP3, FLT3, HTR5A, RELA, SRC |
3.98498 |
[BP] GO:0045776 |
None
|
ADORA1, ADRB1, CNR1, DRD2, DRD3 |
3.96585 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, APEX1, APP, AR, AXL, CYP1A1, CYP1B1, DRD1, EGFR, ERBB2, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, MMP2, RELA, SRC |
3.96585 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, GLO1, MIF, PTGES, TBXAS1 |
3.9285 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, DRD3, MAOA |
3.92208 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, DRD3, MAOA |
3.92208 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, SRC |
3.92208 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, APEX1, APP, AR, AXL, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, ERBB2, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, MMP2, MMP9, RELA, SRC |
3.89457 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA1A, ADRB1, AKR1B1, APP, AR, AURKB, AXL, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FABP4, FLT3, GRM1, HTR2A, HTR2B, HTR6, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP2, MMP9, RELA, SRC, TNKS, TNKS2, XDH |
3.89319 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA1A, APP, AR, CSNK2A1, DRD2, EGFR, ERBB2, F3, FLT3, GRM1, GRM5, HTR2A, HTR2B, KDR, MAP2K1, MAP3K7, MIF, MMP9, RELA, SRC, XDH |
3.89068 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, CSNK2A1, DRD1, DRD2, DRD3, HTR1A, MAOA |
3.88176 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRB1, AKR1B1, APEX1, APP, AR, AURKB, AXL, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, EGFR, ERBB2, FABP3, FABP4, GLO1, GRM3, GRM8, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MET, MIF, MMP9, PIM1, PTGES, RELA, SRC, TNKS, TNKS2, TOP2A, XDH |
3.86198 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA1A, ADRB1, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, GRM1, HTR2A, HTR2B, HTR6, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP9, RELA, SRC, TNKS, TNKS2, XDH |
3.86198 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CNR1, CNR2, CYP19A1, DRD1, DRD2, DRD3, EGFR, F3, FABP4, KDR, MAP2K1, MET, MIF, RELA |
3.84837 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CACNA1C, CNR1, CYP19A1, DRD2, DRD3, EGFR, GRIK5, HTR1A, HTR2A, HTR2B, MIF, SRC |
3.83922 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADRA1A, APP, AR, DRD1, DRD2, EGFR, ERBB2, FABP4, FLT3, GRM1, GRM5, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MIF, MMP9, RELA, SRC, XDH |
3.83922 |
[BP] GO:0019725 |
cellular homeostasis
|
ADRA1A, APEX1, APP, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, GRIK5, GRM1, GRM5, HTR2A, HTR2B, POLA1 |
3.83527 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, DRD3, HTR2A |
3.83361 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP2D6, CYP3A4 |
3.82847 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA1A, ADRB1, APP, AR, AURKB, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, GRM1, GRM5, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP9, RELA, SRC, TNKS, TNKS2, TOP2A, XDH |
3.75019 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, GRM1, HTR2A, HTR2B, IGF1R, MAP2K1, MAP3K7, MIF, SRC |
3.74335 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
ADRA1A, APP, CACNA1C, DRD1, DRD2, DRD3, EGFR, GRM1, GRM5, HTR2A, HTR2B |
3.71551 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, FABP3, SLC1A1 |
3.71551 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, MMP9, RELA, SRC |
3.70602 |
[BP] GO:2001023 |
None
|
CNR1, DRD1, DRD2, DRD3, HTR2A, MET |
3.63571 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CNR1, CNR2, CSNK2A1, CYP1B1, CYP2D6, DRD2, DRD3, FABP4, GRM3, IGF1R, MET, MMP9, PIM1, SRC, TNKS |
3.63539 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA1A, ADRB1, APP, AURKB, DRD2, EGFR, ERBB2, F3, FLT3, GRM1, GRM5, HTR2A, HTR2B, MAP2K1, MAP3K7, MIF, SRC, TNKS, XDH |
3.6275 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA1A, ADRB1, CACNA1C, CHRM2, DRD2, DRD3, EGFR, GRM1, HTR2A, SLC1A1 |
3.62062 |
[BP] GO:0009820 |
alkaloid metabolic process
|
CYP1A2, CYP2D6, CYP3A4 |
3.60982 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, ADRA1A, AKR1B1, APP, AR, AXL, CA2, CACNA1C, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ERBB2, FLT3, HSD17B2, HSD17B3, HTR5A, KDR, MAP2K1, MMP9, PIM1, POLB, RELA, SIGMAR1, SRC, TYR |
3.59603 |
[BP] GO:0019933 |
None
|
ADRA1A, ADRB1, DRD1, DRD2, DRD3, HTR5A |
3.58957 |
[BP] GO:0006811 |
None
|
ADRA1A, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, DRD1, DRD2, DRD3, FABP3, GRIA2, GRIA4, GRIK5, HTR2A, HTR2B, SLC1A1 |
3.58957 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA1A, ADRB1, APP, AR, AURKB, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FABP3, FLT3, GRM1, GRM5, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP9, RELA, SRC, TNKS, TNKS2, TOP2A, XDH |
3.58262 |
[BP] GO:0050890 |
None
|
ADORA1, APP, CNR1, DRD1, DRD2, DRD3, EGFR, GRM5, HTR2A |
3.58262 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.53508 |
[BP] GO:0007202 |
None
|
ADRA1A, EGFR, HTR2A, HTR2B |
3.53508 |
[BP] GO:0055080 |
cation homeostasis
|
ADRA1A, APP, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, EGFR, GRM1, GRM5, HTR2A, HTR2B |
3.53183 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, APP, AXL, CA2, CA7, CACNA1C, CNR1, CYP19A1, DRD1, DRD2, DRD3, EGFR, ERBB2, GRIK5, GRM5, HTR1A, HTR2A, HTR2B, MAP2K1, MIF, MMP9, SRC |
3.52975 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, CACNA1C, CNR1, CYP19A1, DRD2, DRD3, EGFR, GRIK5, HTR1A, HTR2A, HTR2B, MIF, SRC |
3.51662 |
[BP] GO:0009410 |
None
|
CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, RELA |
3.5161 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, DRD1, EGFR, KDR, RELA, SRC |
3.46653 |
[BP] GO:0008217 |
None
|
ADORA1, ADRA1A, ADRB1, AR, CNR1, DRD2, DRD3 |
3.46086 |
[BP] GO:0051940 |
None
|
DRD1, DRD2, DRD3 |
3.43382 |
[BP] GO:0051584 |
None
|
DRD1, DRD2, DRD3 |
3.43382 |
[BP] GO:0030817 |
None
|
ADRB1, DRD1, DRD2, DRD3, GRM3, GRM8 |
3.42669 |
[BP] GO:0035235 |
None
|
APP, GRIA2, GRIA4, GRIK5 |
3.40939 |
[BP] GO:0001975 |
None
|
CNR2, DRD1, DRD2, DRD3 |
3.40939 |
[BP] GO:0019935 |
None
|
ADRA1A, ADRB1, DRD1, DRD2, DRD3, HTR5A |
3.38052 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, APEX1, APP, AXL, CA2, CA9, CNR2, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ERBB2, HTR1A, MAP2K1, MAP3K7, MIF, MMP2, MMP9, POLA1, POLB, PTGES, RELA, SRC, TOP2A |
3.38046 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
ADRA1A, APP, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, GRIK5, GRM1, GRM5, HTR2A, HTR2B |
3.37238 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, ADRB1, AKR1B1, ALDH2, ALOX5, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSD17B3, HTR1A, HTR2B, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, PTGES, RELA, SRC, TBXAS1, TNKS, TNKS2, TOP2A, TYR, XDH |
3.36684 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, ALDH2, ALOX5, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, EGFR, ERBB2, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSD17B3, HTR1A, HTR2B, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP2, PIM1, POLA1, POLB, PTGES, RELA, SRC, TBXAS1, TNKS, TNKS2, TOP2A, TYR, XDH |
3.34727 |
[BP] GO:0070988 |
demethylation
|
APEX1, CYP1A1, CYP1A2, CYP2D6, CYP3A4 |
3.32228 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, DRD1, EGFR, ERBB2, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, SRC, TNKS, TOP2A |
3.32228 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, DRD3, MAOA |
3.29146 |
[BP] GO:0014059 |
None
|
CNR1, DRD2, DRD3, HTR2A |
3.29146 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
ADRA1A, APP, CACNA1C, DRD1, DRD2, DRD3, GRM1, GRM5, HTR2A, HTR2B |
3.28918 |
[BP] GO:0071073 |
None
|
FABP3, HTR2A, HTR2B |
3.28693 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA1A, ADRB1, APP, AR, AURKB, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FABP3, FLT3, GRM1, GRM5, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP9, RELA, SRC, TNKS, TNKS2, TOP2A, XDH |
3.28693 |
[BP] GO:0030003 |
cellular cation homeostasis
|
ADRA1A, APP, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, GRM1, GRM5, HTR2A, HTR2B |
3.28693 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, RELA |
3.26524 |
[BP] GO:0006721 |
terpenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, EGFR |
3.23678 |
[BP] GO:0050730 |
None
|
ADORA1, APP, EGFR, FLT3, GRM5, HTR2A, MIF, SRC |
3.21702 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, RELA, SRC |
3.21647 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA1A, APP, AR, DRD2, EGFR, ERBB2, F3, FLT3, GRM1, GRM5, HTR2A, HTR2B, KDR, MAP2K1, MAP3K7, MIF, MMP9, SRC, XDH |
3.20781 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APEX1, APP, AR, DRD1, EGFR, ERBB2, FLT3, GRM5, IGF1R, MMP2, RELA, SRC |
3.19102 |
[BP] GO:0006873 |
cellular ion homeostasis
|
ADRA1A, APP, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, GRM1, GRM5, HTR2A, HTR2B |
3.19102 |
[BP] GO:0055074 |
calcium ion homeostasis
|
ADRA1A, APP, CACNA1C, DRD1, DRD2, DRD3, GRM1, GRM5, HTR2A, HTR2B |
3.19102 |
[BP] GO:0040011 |
locomotion
|
AXL, CNR2, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, KDR, MAP2K1, MET, MIF, MMP1, MMP9, SRC |
3.18215 |
[BP] GO:0060402 |
None
|
ADRA1A, CACNA1C, DRD2, HTR2A, HTR2B |
3.1762 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, APP, DRD1, EGFR, GRM5, IGF1R, MMP2, RELA, SRC |
3.1762 |
[BP] GO:0007611 |
None
|
APP, CNR1, DRD1, DRD2, DRD3, EGFR, GRM5, HTR2A |
3.17589 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA1A, APP, AR, AURKB, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, GRM1, GRM5, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP9, RELA, SRC, TNKS, TNKS2, TOP2A, XDH |
3.16266 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, CSNK2A1, DRD1, EGFR, ERBB2, FLT3, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TNKS |
3.15932 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, GRM5 |
3.1589 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.1589 |
[BP] GO:0008016 |
None
|
ADORA1, ADORA3, ADRA1A, ADRB1, CACNA1C, CHRM2, DRD2, SLC1A1 |
3.15768 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
ADRA1A, APP, CACNA1C, DRD1, DRD2, DRD3, GRM1, GRM5, HTR2A, HTR2B |
3.15768 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA1A, AR, CNR2, DRD1, DRD2, DRD3, EGFR, ERBB2, HTR2A, IGF1R, MET, MIF, MMP9, RELA, SRC, XDH |
3.14994 |
[BP] GO:0014065 |
phosphatidylinositol 3-kinase signaling
|
ERBB2, HTR2A, HTR2B, IGF1R |
3.14766 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA1A, AR, CNR2, DRD1, DRD2, DRD3, EGFR, ERBB2, HTR2A, IGF1R, MET, MIF, MMP9, RELA, SRC, XDH |
3.13568 |
[BP] GO:0048870 |
cell motility
|
AXL, CNR2, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, KDR, MAP2K1, MIF, MMP1, MMP9, SRC |
3.13568 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6, CYP3A4 |
3.11029 |
[BP] GO:0010038 |
response to metal ion
|
APP, CA2, CYP1A1, CYP1A2, DRD2, EGFR, FABP4, MMP9, PTGES |
3.10781 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
ADRB1, APP, DRD2, DRD3, TNKS2 |
3.10367 |
[BP] GO:0022029 |
None
|
DRD1, DRD2, EGFR, HTR6 |
3.10367 |
[BP] GO:0043278 |
None
|
CNR1, DRD2, DRD3, RELA |
3.10367 |
[BP] GO:0014072 |
None
|
CNR1, DRD2, DRD3, RELA |
3.10367 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, PTGES, RELA, SRC |
3.08229 |
[BP] GO:0030814 |
None
|
ADRB1, DRD1, DRD2, DRD3, GRM3, GRM8 |
3.07666 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
ADRA1A, EGFR, HTR2A, HTR2B |
3.05311 |
[BP] GO:0002031 |
None
|
DRD2, DRD3, HTR2B |
3.04974 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CA9, CSNK2A1, EGFR, RELA, SRC |
3.04312 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRB1, AKR1B1, APEX1, APP, AR, AURKB, AXL, CA1, CA2, CA7, CA9, CACNA1C, CHRM2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FABP3, FABP4, FLT3, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, PTGES, RELA, SIGMAR1, SRC, TNKS, TNKS2, TOP2A, XDH |
3.02942 |
[BP] GO:1903524 |
None
|
ADRA1A, ADRB1, EGFR, HTR2A, SLC1A1 |
3.02667 |
[BP] GO:0030802 |
None
|
ADRB1, DRD1, DRD2, DRD3, GRM3, GRM8 |
3.02667 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR, RELA |
3.00856 |
[BP] GO:0016477 |
cell migration
|
AXL, CNR2, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, KDR, MIF, MMP1, MMP9, SRC |
2.97731 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, SRC |
2.97335 |
[BP] GO:0007189 |
None
|
ADRA1A, ADRB1, DRD1, DRD2, DRD3 |
2.97335 |
[BP] GO:0042738 |
exogenous drug catabolic process
|
CYP1A2, CYP2A6, CYP3A4 |
2.94461 |
[BP] GO:0070989 |
oxidative demethylation
|
CYP1A2, CYP2D6, CYP3A4 |
2.94461 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APEX1, APP, DRD1, EGFR, GRM5, IGF1R, MMP2, RELA, SRC |
2.92955 |
[BP] GO:1900274 |
regulation of phospholipase C activity
|
ADRA1A, EGFR, HTR2A, HTR2B |
2.92567 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, EGFR |
2.92051 |
[BP] GO:0001997 |
None
|
ADRA1A, ADRB1 |
2.91545 |
[BP] GO:0006286 |
base-excision repair, base-free sugar-phosphate removal
|
APEX1, POLB |
2.91545 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD17B1, HSD17B2, HSD17B3 |
2.90634 |
[BP] GO:0050789 |
regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRB1, AKR1B1, APEX1, APP, AR, AURKB, AXL, CA1, CA2, CA7, CA9, CACNA1C, CHRM2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FABP3, FABP4, FLT3, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, PTGES, RELA, SIGMAR1, SLC1A1, SRC, TNKS, TNKS2, TOP2A, XDH |
2.90634 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, APP, AXL, CYP1B1, EGFR, MMP9, RELA, SRC |
2.90278 |
[BP] GO:0046883 |
regulation of hormone secretion
|
ADORA1, CACNA1C, CNR1, CYP19A1, DRD2, EGFR, HTR1A, HTR2A |
2.88699 |
[BP] GO:0060401 |
None
|
ADRA1A, CACNA1C, DRD2, HTR2A, HTR2B |
2.87775 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, GLO1, MIF, PIM1, PTGES, TBXAS1, TYR |
2.86384 |
[BP] GO:1900371 |
None
|
ADRB1, DRD1, DRD2, DRD3, GRM3, GRM8 |
2.85544 |
[BP] GO:0060078 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5, GRM5 |
2.85465 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.85465 |
[BP] GO:0060134 |
None
|
DRD1, DRD2, DRD3 |
2.85465 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
ADRA1A, CA2, CA7 |
2.85465 |
[BP] GO:0014075 |
None
|
CNR2, DRD1, DRD2, DRD3 |
2.85184 |
[BP] GO:0030808 |
None
|
ADRB1, DRD1, DRD2, DRD3, GRM3, GRM8 |
2.84504 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
APEX1, APP, AR, CYP1A1, CYP1B1, DRD1, EGFR, FLT3, SRC |
2.83878 |
[BP] GO:0007610 |
None
|
APP, CNR1, DRD1, DRD2, DRD3, EGFR, GRM1, GRM5, HTR1A, HTR2A, HTR2B |
2.83315 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, FABP3, SLC1A1 |
2.80004 |
[BP] GO:0055065 |
metal ion homeostasis
|
ADRA1A, APP, CACNA1C, DRD1, DRD2, DRD3, EGFR, GRM1, GRM5, HTR2A, HTR2B |
2.80004 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
ADRB1, APP, AR, AURKB, DRD1, DRD2, DRD3, EGFR, ERBB2, FABP3, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MET, RELA, SRC, TNKS, TNKS2, TOP2A |
2.77508 |
[BP] GO:0051580 |
None
|
DRD1, DRD2, DRD3 |
2.76336 |
[BP] GO:0051967 |
None
|
ADORA1, DRD2, HTR2A |
2.76336 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, APEX1, APP, AURKB, AXL, CSNK2A1, DRD1, DRD2, EGFR, ERBB2, FLT3, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, POLB, SRC, TNKS, XDH |
2.76315 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, CACNA1C, CNR1, DRD2, DRD3, EGFR, HTR2B, MIF, SRC |
2.76298 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRB1, APEX1, APP, AR, AURKB, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP9, PIM1, POLA1, RELA, SRC, TNKS, TNKS2, TOP2A, XDH |
2.76096 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
AXL, CNR1, CNR2, CYP1A1, CYP1A2, PTGES, RELA, SRC |
2.75269 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HSD17B1, HSD17B2, HSD17B3, MIF, PTGES |
2.75163 |
[BP] GO:0044070 |
regulation of anion transport
|
ADORA1, CA2, CA7, GRM5, MIF |
2.74517 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CNR1, CYP1A1, DRD3, FABP3, FLT3, HTR2A, HTR2B, SRC |
2.74108 |
[BP] GO:0050877 |
None
|
ADORA1, APP, CNR1, CNR2, CYP1B1, DRD1, DRD2, DRD3, EGFR, GRM1, GRM5, GRM8, HTR2A, TYR |
2.70874 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, ALDH2, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP3A4, FABP3, FABP4, FUT7, MAOA, MMP1, MMP2, MMP9, SRC, XDH |
2.70066 |
[BP] GO:1901224 |
None
|
APP, EGFR, MAP3K7, RELA |
2.70059 |
[BP] GO:0090066 |
None
|
ADORA1, ADRA1A, ADRB1, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7 |
2.69136 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, DRD2, DRD3, EGFR, HTR7, SRC, TOP2A |
2.68613 |
[BP] GO:0001963 |
None
|
DRD1, DRD2, DRD3 |
2.68418 |
[BP] GO:0051480 |
regulation of cytosolic calcium ion concentration
|
ADRA1A, CACNA1C, DRD1, DRD2, GRM1, GRM5, HTR2A, HTR2B |
2.67938 |
[BP] GO:0009416 |
response to light stimulus
|
APP, AURKB, DRD1, DRD2, DRD3, EGFR, RELA, TYR |
2.67938 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APEX1, APP, AURKB, CYP1A1, DRD2, DRD3, EGFR, MIF, SRC |
2.67938 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APEX1, APP, GRM5, IGF1R, RELA, SRC |
2.67938 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, CNR1, DRD2, DRD3, HTR2A, MMP9 |
2.67774 |
[BP] GO:0030799 |
None
|
ADRB1, DRD1, DRD2, DRD3, GRM3, GRM8 |
2.66276 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRB1, APEX1, APP, AR, AURKB, CA9, CNR1, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP9, PIM1, POLA1, RELA, SRC, TNKS, TNKS2, TOP2A, XDH |
2.64839 |
[BP] GO:0050808 |
None
|
ACHE, APP, DRD1, DRD2, ERBB2, GRM5 |
2.64791 |
[BP] GO:0030818 |
None
|
DRD2, DRD3, GRM3, GRM8 |
2.63558 |
[BP] GO:0050999 |
None
|
CNR1, CNR2, EGFR, HTR2B |
2.63558 |
[BP] GO:0060359 |
None
|
CNR1, DRD1, DRD2, DRD3, RELA |
2.61985 |
[BP] GO:0071071 |
None
|
FABP3, HTR2A, HTR2B |
2.61225 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, DRD3 |
2.61225 |
[BP] GO:0097366 |
None
|
CNR2, DRD1, DRD2, DRD3 |
2.60214 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, EGFR, HTR2B, MIF, SRC |
2.596 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
APP, AR, AURKB, AXL, CNR1, DRD2, DRD3, IGF1R, KDR, MAP2K1, MET, MMP1, MMP9, SRC, TNKS, TNKS2 |
2.59258 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
AXL, CNR1, CNR2, CYP1A1, CYP1A2, PTGES, RELA, SRC |
2.5817 |
[BP] GO:0051588 |
None
|
DRD1, DRD2, DRD3, GRIK5, HTR1A |
2.5817 |
[BP] GO:0030803 |
None
|
DRD2, DRD3, GRM3, GRM8 |
2.56955 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
ADRA1A, APP, CACNA1C, DRD1, DRD2, DRD3, GRM1, GRM5, HTR2A, HTR2B |
2.54346 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.53825 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, APP, CA2, CACNA1C, CNR1, DRD2, DRD3, EGFR, ERBB2, HTR2B, MIF, SRC |
2.53825 |
[BP] GO:0050433 |
None
|
CNR1, DRD2, DRD3, HTR2A |
2.53777 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, KDR, SRC |
2.53777 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, ERBB2, F3, MET, SRC |
2.52753 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, APP, CNR1, CNR2, CYP19A1, DRD2, EGFR, F3, FABP4, IGF1R, MAP2K1, MAP3K7, MET, MIF, MMP2, RELA, SRC, XDH |
2.52753 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.52753 |
[BP] GO:0033590 |
None
|
EGFR, RELA |
2.52753 |
[BP] GO:0098502 |
DNA dephosphorylation
|
APEX1, POLB |
2.52753 |
[BP] GO:0009822 |
alkaloid catabolic process
|
CYP2D6, CYP3A4 |
2.52753 |
[BP] GO:0001996 |
None
|
ADRA1A, ADRB1 |
2.52753 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.52753 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.52753 |
[BP] GO:0003099 |
None
|
ADRA1A, ADRB1 |
2.52753 |
[BP] GO:0033602 |
None
|
CNR1, DRD2 |
2.52753 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, APP, AR, CYP1B1, DRD2, ERBB2, FABP3, MAP2K1, PTGES, XDH |
2.52658 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, APEX1, APP, AURKB, AXL, CSNK2A1, DRD1, DRD2, EGFR, ERBB2, FLT3, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, POLB, SRC, TNKS, XDH |
2.52134 |
[BP] GO:0008542 |
None
|
APP, DRD1, DRD2, DRD3 |
2.52134 |
[BP] GO:0030815 |
None
|
DRD2, DRD3, GRM3, GRM8 |
2.52134 |
[BP] GO:1900372 |
None
|
DRD2, DRD3, GRM3, GRM8 |
2.48989 |
[BP] GO:0030809 |
None
|
DRD2, DRD3, GRM3, GRM8 |
2.48989 |
[BP] GO:0010518 |
positive regulation of phospholipase activity
|
ADRA1A, EGFR, HTR2A, HTR2B |
2.48989 |
[BP] GO:0014821 |
None
|
DRD1, DRD2, HTR2B |
2.48847 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, GLO1, MIF, PIM1, PTGES, TBXAS1, TYR |
2.48462 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, MMP2, MMP9, SRC |
2.47271 |
[BP] GO:0002027 |
None
|
ADRA1A, ADRB1, CACNA1C, DRD2, SLC1A1 |
2.46143 |
[BP] GO:0030800 |
None
|
DRD2, DRD3, GRM3, GRM8 |
2.46118 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA1A, AR, CNR1, CNR2, CYP19A1, DRD1, DRD2, DRD3, EGFR, ERBB2, IGF1R, MET, MIF, MMP9, RELA, SRC, XDH |
2.45653 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
ADRB1, APP, AR, AURKB, DRD1, DRD2, DRD3, EGFR, ERBB2, FABP3, HTR2A, HTR2B, IGF1R, MAP2K1, MET, RELA, SRC, TNKS, TNKS2, TOP2A |
2.44335 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.42613 |
[BP] GO:1901184 |
None
|
ADORA1, APP, EGFR, ERBB2, MMP9 |
2.42613 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, APP, AXL, CA2, CYP19A1, DRD1, DRD2, DRD3, EGFR, ERBB2, HTR2B, MIF, SRC |
2.4218 |
[BP] GO:1900542 |
None
|
ADRB1, DRD1, DRD2, DRD3, GRM3, GRM8, HTR2A |
2.41841 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, GLO1, MIF, PIM1, PTGES, TBXAS1, TYR |
2.41418 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HTR2A, MET, SRC |
2.39165 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HTR2A, MET, SRC |
2.39165 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HTR2A, MET, SRC |
2.39165 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HTR2A, MET, SRC |
2.39165 |
[BP] GO:0098900 |
None
|
ADRA1A, CACNA1C, CNR1, CNR2 |
2.37791 |
[BP] GO:0007632 |
None
|
APP, DRD1, DRD2, DRD3 |
2.37791 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.37791 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.36966 |
[BP] GO:0071880 |
None
|
ADRA1A, ADRB1, DRD2 |
2.36966 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
ADRA1A, DRD2, DRD3, IGF1R, MET, MIF, MMP9, RELA, SRC, XDH |
2.36683 |
[BP] GO:0006140 |
None
|
ADRB1, DRD1, DRD2, DRD3, GRM3, GRM8, HTR2A |
2.35192 |
[BP] GO:0000186 |
activation of MAPKK activity
|
ADORA1, EGFR, GRM1, MAP3K7 |
2.35168 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRA1A, ADRB1, APEX1, APP, AR, AURKB, CA9, CNR1, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP9, PIM1, POLA1, RELA, SRC, TNKS, TNKS2, TOP2A, XDH |
2.34703 |
[BP] GO:0048732 |
gland development
|
AR, CSNK2A1, CYP19A1, EGFR, MAP2K1, RELA, TYR |
2.34355 |
[BP] GO:0006928 |
movement of cell or subcellular component
|
APP, AXL, CNR2, CYP1B1, DRD1, DRD2, EGFR, ERBB2, FUT7, HTR2B, HTR6, KDR, MAP2K1, MIF, MMP1, MMP9, SRC |
2.33978 |
[BP] GO:0009314 |
response to radiation
|
APP, AURKB, DRD1, DRD2, DRD3, EGFR, POLB, RELA, TYR |
2.33063 |
[BP] GO:0031623 |
None
|
ACHE, DRD2, DRD3, HTR2B |
2.326 |
[BP] GO:0032768 |
None
|
CNR1, CNR2, EGFR, HTR2B |
2.326 |
[BP] GO:0050708 |
None
|
ACHE, CACNA1C, CNR1, DRD2, DRD3, EGFR, HTR2B, MIF, SRC |
2.31787 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.31545 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APEX1, APP, AR, AURKB, CNR1, CNR2, CSNK2A1, CYP2D6, DRD2, DRD3, EGFR, FABP4, GRM3, GRM8, HTR2B, IGF1R, KDR, MAP2K1, MET, MIF, MMP9, RELA, SRC, TNKS, TNKS2, XDH |
2.3107 |
[BP] GO:0007204 |
positive regulation of cytosolic calcium ion concentration
|
ADRA1A, CACNA1C, DRD1, DRD2, GRM1, HTR2A, HTR2B |
2.28487 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.28119 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.28119 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.28119 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.28119 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, FLT3, GRM5, HTR2A, MIF, SRC |
2.27908 |
[BP] GO:0072347 |
None
|
CNR1, DRD2, DRD3, RELA |
2.27908 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP1A1, CYP1A2, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, FUT7, GLO1, HTR1A, HTR2B, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIM1, POLB, RELA, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
2.27908 |
[BP] GO:0050679 |
None
|
AR, EGFR, ERBB2, F3, HTR2B, KDR |
2.25451 |
[BP] GO:0010517 |
regulation of phospholipase activity
|
ADRA1A, EGFR, HTR2A, HTR2B |
2.22457 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, DRD2, EGFR, HTR2B, MIF, SRC |
2.22457 |
[BP] GO:0051953 |
None
|
ADORA1, CNR1, DRD2 |
2.21303 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.21303 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.21303 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, CYP1A1, DRD2, EGFR, ERBB2 |
2.20766 |
[BP] GO:0007626 |
None
|
APP, DRD1, DRD2, DRD3, GRM1, GRM5 |
2.20766 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, DRD1, EGFR, F3, IGF1R, KDR, MET, MMP9, SRC |
2.20444 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.20274 |
[BP] GO:0051282 |
None
|
CACNA1C, DRD1, DRD2, HTR2A, HTR2B |
2.20274 |
[BP] GO:0019722 |
calcium-mediated signaling
|
CACNA1C, EGFR, GRM5, HTR2B, KDR |
2.20274 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, APP, FABP3, GRM5, IGF1R, RELA, SRC |
2.17813 |
[BP] GO:0048015 |
phosphatidylinositol-mediated signaling
|
ERBB2, HTR2A, HTR2B, IGF1R |
2.17813 |
[BP] GO:0010460 |
None
|
ADRA1A, ADRB1, SLC1A1 |
2.16613 |
[BP] GO:0071875 |
None
|
ADRA1A, ADRB1, DRD2 |
2.16613 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.16613 |
[BP] GO:1901222 |
None
|
APP, EGFR, MAP3K7, RELA |
2.15586 |
[BP] GO:0060193 |
positive regulation of lipase activity
|
ADRA1A, EGFR, HTR2A, HTR2B |
2.15586 |
[BP] GO:0003012 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
2.14756 |
[BP] GO:0030336 |
None
|
ADORA1, ADORA3, APEX1, CYP19A1, CYP1B1, DRD2, MIF |
2.13833 |
[BP] GO:0048169 |
None
|
APP, DRD2, GRM5 |
2.11807 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MAP3K7, MET, MMP2, MMP9, SRC |
2.11501 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.10829 |
[BP] GO:0048017 |
inositol lipid-mediated signaling
|
ERBB2, HTR2A, HTR2B, IGF1R |
2.10829 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, DRD1, EGFR, F3, IGF1R, KDR, MET, MMP9, SRC |
2.10548 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, CYP19A1, HSD17B2, HSD17B3, MAP2K1, SRC |
2.09906 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
2.09906 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.09906 |
[BP] GO:0098501 |
polynucleotide dephosphorylation
|
APEX1, POLB |
2.09906 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
CYP19A1, HSD17B3 |
2.09906 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.09906 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.09906 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.09906 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.09906 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B |
2.09906 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.08144 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.08144 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, ADRA1A, APP, AR, CSNK2A1, DRD1, DRD2, EGFR, ERBB2, F3, FABP4, FLT3, GRM1, GRM5, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MIF, MMP9, RELA, SRC, XDH |
2.06829 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, SRC |
2.05768 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.03746 |
[BP] GO:1904646 |
cellular response to amyloid-beta
|
APP, GRM5, IGF1R |
2.03746 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, DRD1, EGFR, F3, IGF1R, KDR, MET, MMP9, SRC |
2.03362 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CNR2, CYP19A1, DRD1, DRD2, DRD3, MIF |
2.02671 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
CNR1, EGFR, F3, FABP4, KDR, MET, MIF |
2.02671 |
[BP] GO:2000146 |
None
|
ADORA1, ADORA3, APEX1, CYP19A1, CYP1B1, DRD2, MIF |
2.01806 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, ADRA1A, ADRB1, APEX1, APP, AR, AURKB, CA9, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP9, PIM1, POLA1, RELA, SRC, TNKS, TNKS2, TOP2A, XDH |
2.01523 |
[BP] GO:0042180 |
None
|
AKR1B1, CYP19A1, GLO1, HSD17B3 |
2.00596 |
[BP] GO:0060079 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5 |
2.00596 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, ADRB1, APP, AXL, CA4, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, F3, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1, SLC1A1 |
10.2492 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRB1, ALOX5, APP, AR, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CHRM2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, FUT7, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD17B2, HSD17B3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP2, PIM1, PTGES, SIGMAR1, SLC1A1, SRC, TBXAS1, TNKS, TNKS2, TYR |
9.44063 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, ADRB1, APP, AXL, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1, SLC1A1 |
9.30423 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRA1A, ADRB1, APP, AXL, CA2, CA4, CA9, CACNA1C, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1, SLC1A1, SRC |
9.21675 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRB1, APP, AR, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CHRM2, CNR1, CNR2, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP2, PIM1, SLC1A1, SRC |
7.98627 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, ADRA1A, CA2, CA4, CA9, CHRM2, CNR1, DRD1, DRD2, EGFR, ERBB2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR2A, MET, SIGMAR1, SLC1A1, SRC |
7.94963 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRB1, APP, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CHRM2, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, FUT7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD17B2, HSD17B3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MAOA, MET, PTGES, SIGMAR1, SLC1A1, SRC, TBXAS1, TYR |
6.51116 |
[CC] GO:0044456 |
None
|
ACHE, ADORA1, APP, CACNA1C, CHRM2, CNR1, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SIGMAR1, SRC |
5.10983 |
[CC] GO:0043005 |
None
|
ADORA1, APP, CA2, CHRM2, CNR1, CNR2, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR2B, HTR5A, SRC |
5.10297 |
[CC] GO:0014069 |
None
|
ADORA1, CACNA1C, DRD2, GRIK5, GRM1, GRM3, GRM5, SIGMAR1, SRC |
4.57685 |
[CC] GO:0099572 |
None
|
ADORA1, CACNA1C, DRD2, GRIK5, GRM1, GRM3, GRM5, SIGMAR1, SRC |
4.57685 |
[CC] GO:0042734 |
None
|
CNR1, GRIK5, GRM1, GRM3, GRM5, GRM8 |
4.45218 |
[CC] GO:0042995 |
cell projection
|
ADORA1, AKR1B1, APP, CA2, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR2B, HTR5A, HTR6, SRC |
4.33676 |
[CC] GO:0031224 |
None
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRB1, APP, AXL, CA12, CA14, CA4, CA9, CACNA1C, CHRM2, CNR1, CNR2, CYP3A4, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, FUT7, GRIA2, GRM1, GRM3, GRM5, GRM8, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MAOA, MET, PTGES, SIGMAR1, SLC1A1, TBXAS1, TYR |
4.33295 |
[CC] GO:0097060 |
None
|
CHRM2, CNR1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SIGMAR1 |
4.251 |
[CC] GO:0120025 |
None
|
ADORA1, AKR1B1, APP, CA2, CHRM2, CNR1, CNR2, DRD1, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR2B, HTR5A, HTR6, SRC |
4.10362 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, ADRA1A, ADRB1, AKR1B1, ALDH2, ALOX5, APEX1, APP, AR, AURKB, CA1, CA2, CA4, CA7, CACNA1C, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, EGFR, ERBB2, FABP3, FABP4, FLT3, FUT7, GLO1, GRIA2, GRIA4, GRIK5, HSD17B1, HSD17B2, HSD17B3, HTR2A, HTR5A, KDR, MAOA, MAP2K1, MAP3K7, MIF, MMP2, MMP9, PIM1, POLA1, PTGES, RELA, SIGMAR1, SRC, TBXAS1, TNKS, TNKS2, TOP2A, TYR, XDH |
4.00683 |
[CC] GO:0016021 |
None
|
ADORA1, ADORA3, ADRA1A, ADRB1, APP, AXL, CA12, CA14, CA9, CACNA1C, CHRM2, CNR1, CNR2, CYP3A4, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, FUT7, GRIA2, GRM1, GRM3, GRM5, GRM8, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MAOA, MET, PTGES, SIGMAR1, SLC1A1, TBXAS1, TYR |
3.84433 |
[CC] GO:0097458 |
None
|
ADORA1, APP, CA2, CACNA1C, CHRM2, CNR1, CNR2, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR2A, HTR2B, HTR5A, SIGMAR1, SRC |
3.71872 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, EGFR, GRIA2, HSD17B2, HSD17B3, PTGES, SIGMAR1, TBXAS1 |
3.70602 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP, PTGES |
3.43382 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, EGFR, FLT3, GRIA2, HSD17B2, HSD17B3, PTGES, SIGMAR1, TBXAS1 |
3.12341 |
[CC] GO:0044463 |
None
|
ADORA1, AKR1B1, APP, CA4, CA9, CHRM2, CNR1, DRD1, DRD2, GRIA2, GRIA4, GRIK5, GRM3, HTR2A, SIGMAR1, SRC |
3.05249 |
[CC] GO:0120038 |
None
|
ADORA1, AKR1B1, APP, CA4, CA9, CHRM2, CNR1, DRD1, DRD2, GRIA2, GRIA4, GRIK5, GRM3, HTR2A, SIGMAR1, SRC |
3.05249 |
[CC] GO:0043197 |
None
|
ADORA1, APP, DRD2, GRIA2, GRIA4, GRM3 |
3.04312 |
[CC] GO:0044309 |
None
|
ADORA1, APP, DRD2, GRIA2, GRIA4, GRM3 |
3.00856 |
[CC] GO:0031090 |
None
|
ADRA1A, ALOX5, APP, CA4, CHRM2, CNR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, EGFR, ERBB2, FUT7, GRIA2, GRIA4, MAOA, MAP3K7, SIGMAR1, SRC, TNKS, TNKS2, TYR |
2.80034 |
[CC] GO:0098794 |
None
|
ADORA1, APP, DRD2, GRIA2, GRIA4, GRM3 |
2.52753 |
[CC] GO:0005783 |
None
|
ADORA1, APEX1, APP, CA4, CYP19A1, CYP2D6, FLT3, GRIK5, HSD17B3, HTR5A, KDR, MAP2K1, SIGMAR1, XDH |
2.51301 |
[CC] GO:0043235 |
receptor complex
|
APP, EGFR, ERBB2, GRIA2, GRIA4, GRIK5, GRM1, IGF1R |
2.37791 |
[CC] GO:0048471 |
perinuclear region of cytoplasm
|
ACHE, AKR1B1, APEX1, APP, CA4, EGFR, ERBB2, PTGES, SRC, TNKS2, TYR |
2.25451 |
[CC] GO:0043226 |
organelle
|
ACHE, ADORA1, ADRA1A, ADRB1, AKR1B1, ALDH2, APEX1, APP, AR, AURKB, AXL, CA1, CA2, CA4, CA9, CACNA1C, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FABP3, FABP4, FLT3, FUT7, GLO1, GRIA4, GRIK5, GRM1, GRM3, GRM5, HSD17B3, HTR2A, HTR5A, HTR6, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MIF, MMP2, MMP9, PIM1, POLA1, POLB, RELA, SHBG, SIGMAR1, SLC1A1, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
2.15586 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, EGFR, ERBB2 |
2.13007 |
[MF] GO:0030594 |
None
|
CHRM2, DRD1, DRD2, DRD3, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
13.8179 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA1A, ADRB1, AXL, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
12.5774 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, ADRB1, AXL, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
12.5774 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, ADRB1, AR, AXL, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
12.4233 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA1A, ADRB1, AR, AXL, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MAP2K1, MAP3K7, MET, SIGMAR1 |
11.5765 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA1A, ADRB1, AR, AXL, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
11.2149 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA1A, ADRB1, AR, AXL, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
10.8503 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FABP3, FABP4, FLT3, GLO1, HSD17B1, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, PTGES, RELA, SLC1A1, SRC, TBXAS1, TNKS, TNKS2, TOP2A, TYR, XDH |
10.1991 |
[MF] GO:0008227 |
None
|
ADRA1A, ADRB1, CHRM2, DRD2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
10.1572 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4 |
9.83729 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.83268 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, APP, AR, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, GLO1, MMP1, MMP2, MMP9, PIM1, TBXAS1, TNKS, TYR, XDH |
9.5142 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6, CYP3A4 |
8.45866 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, TBXAS1, TYR |
8.15938 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, EGFR, ERBB2, FLT3, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SIGMAR1, SRC, TOP2A |
8.01038 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
7.97277 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
7.84375 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, POLB |
7.75309 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, TBXAS1, XDH |
7.39045 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, ADRA1A, ADRB1, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1 |
7.34791 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, SRC, TBXAS1 |
7.11031 |
[MF] GO:0099528 |
None
|
CHRM2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.03987 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, ALDH2, ALOX5, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, HSD17B1, HSD17B2, HSD17B3, MAOA, TBXAS1, TYR, XDH |
7.0134 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, APEX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, GLO1, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, MAP3K7, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, SLC1A1, TBXAS1, TNKS, TNKS2, TOP2A, TYR, XDH |
6.99767 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, SRC, TBXAS1 |
6.83117 |
[MF] GO:0043176 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.72229 |
[MF] GO:0051378 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.72229 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, ALDH2, ALOX5, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, EGFR, ERBB2, F3, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, PTGES, SRC, TBXAS1, TNKS, TNKS2, TOP2A, TYR, XDH |
6.72229 |
[MF] GO:0004993 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.69128 |
[MF] GO:0099589 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.69128 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6, CYP3A4 |
6.61324 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, TBXAS1, TYR |
6.44639 |
[MF] GO:0048037 |
cofactor binding
|
ALDH2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, HSD17B1, POLA1, PTGES, SRC, TBXAS1, XDH |
6.23189 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.07108 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP2D6, CYP3A4 |
5.85375 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, GLO1, POLB |
5.82061 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET |
5.73692 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET |
5.09464 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
4.86605 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
4.85791 |
[MF] GO:1901338 |
None
|
ADRB1, DRD1, DRD2, DRD3 |
3.83361 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, EGFR, HSD17B1, IGF1R, SHBG |
3.74241 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC |
3.37238 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.28693 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, ERBB2, KDR |
3.28693 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, APEX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, GLO1, MAP3K7, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, SLC1A1, TBXAS1, TNKS, TNKS2, TOP2A, TYR, XDH |
3.05249 |
[MF] GO:0005057 |
signal transducer activity, downstream of receptor
|
ADRB1, EGFR, ERBB2, KDR, MAP2K1, MAP3K7 |
2.97284 |
[MF] GO:0004952 |
None
|
DRD1, DRD2, DRD3 |
2.94461 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.91545 |
[MF] GO:0035240 |
None
|
DRD1, DRD2, DRD3 |
2.85465 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, POLA1, POLB, SRC |
2.72241 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC |
2.67445 |
[MF] GO:0004935 |
None
|
ADRA1A, ADRB1, DRD2 |
2.61225 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.52753 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.52753 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.52753 |
[MF] GO:0046982 |
protein heterodimerization activity
|
ADORA1, ADRA1A, ADRB1, AXL, DRD2, EGFR, ERBB2, RELA, TOP2A, TYR |
2.4852 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.42613 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.42613 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC |
2.35424 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.28119 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.28119 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.28119 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.28119 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, ALDH2, CYP19A1, CYP1A2, XDH |
2.28102 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.09906 |
[MF] GO:0003674 |
molecular_function
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRB1, AKR1B1, ALDH2, ALOX5, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CHRM2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FABP3, FABP4, FLT3, FUT7, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD17B1, HSD17B2, HSD17B3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP2, MMP9, PIM1, POLA1, POLB, PTGES, RELA, SHBG, SIGMAR1, SLC1A1, SRC, TBXAS1, TNKS, TNKS2, TOP2A, TYR, XDH |
2.08144 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, APP, CSNK2A1, DRD2, EGFR, ERBB2, FLT3, GRIK5, IGF1R, KDR, MAP3K7, MET, MIF, MMP9, RELA, TOP2A, TYR, XDH |
2.04447 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA7, CA9, GLO1, MMP1, MMP2, MMP9, TNKS |
2.03746 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD17B1, HSD17B2, HSD17B3 |
2.03746 |